Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
The Kate Spade New York Foundation said in a statement Wednesday it is donating $200,000 to The Jed Foundation, which partners with schools to strengthen mental health programs. The fashion brand will match public donations to JED from Wednesday through June 12, up to $100,000, at jedfoundation.org/katespade. The donations follow money already given to other organizations, including the Crisis Text Line. Anna Bakst, brand president and CEO of Kate Spade New York, said the company hopes to encourage more conversation, education and research around mental health. Spade killed herself June 5, 2018, at 55, after years of battling depression and anxiety.

Ex Output:
Kate Spade New York fulfills $1 million mental health pledge.

Ex Input:
Although there was no discussion of costs, the article was clear in stating that vaccines arefor the most partin an early stage of development, so this omission is understandable. We wanted to seebetter coverage of the data here. The story leads with an anecdote about a patient who kicked a pack-a-day smoking habit after treatment with a nicotinevaccine in a study. And later,the story says that smokers who received thatvaccine were "about three times as likely to be off cigarettes 44 weeks after vaccination than subjects given a placebo."The story should have providedthe absolute rates of success reported in the study, which were only 16% for the treatment group compared with 6% for the placebo group, according to theheart.org. Elsewhere,the storydescribes an experimental anticocaine vaccine that was apparently very effective in a mouse study; it could have reported onphase II human data that is available for theTA-CDanticocaine vaccine that was also mentioned in the story. These data again suggest that only a minority of patientsmay benefit from the use of anti-addictionvaccines. The story states that "clinical trials have so far revealed no significant side effects" from vaccine treatments. However, we think the story should have included an important caveat: that these are early stagetrials involving small numbers of patients thatcan't provideconclusive evidence of safety. In addition, it should be recognized that addictions arechronic conditions and these vaccine treatments are likely to be long-term as well. Therefore, longer-term adverse effects should be expected, especially for a treatment that interferes with molecules closely related to the body's natural chemical messengers. The story could have been a bit more circumspect on this point. The promise of this new vaccine technology is counterbalanced by coverage of the uncertainties. The story gives appropriate weightto thedisappointing resultsreported in a number of early clinical studies, noting: "Failures have so far outnumbered successes." The story adds thateven in one of the successful vaccine studies, the benefitswere not as robust as those seen with a smoking cessation drug that is already on the market. There also is no prospect for a vaccine to treat alcoholism, according to the story. The article should have been more direct about the limitations of mouse research, and there was not enough detailon thedata publishedin the various studies reported on (a deficiency we address under the "Benefits" criterion). However, since the story was trying to present a broad overview of happenings in the field and wasn't attempting to summarize any particular study, we'll give the benefit of the doubt here and award a satisfactory. The story didn't exaggerate the effects ofsubstanceabusedisorders or otherwise engage in disease-mongering. The sourcing of this story was good. We hear fromacademics, government researchers, and industry executives. Their voices provide balance and give texture to the coverage. It should be noted, however, that most of these experts have a vested interest in the field or the success of a particular treatment, whether because of industry ties or because they are leading experiments ona particular approach. Even the government experts might be biased by their provision of significant financial support for research in this area. It would have been nice to heara comment about the vaccines from someonewho is certifiably free of all potential conflicts. But we can't justify docking pointssince there is no voice that is overly enthusiastic about the concept. The story compares the potential of vaccines with the benefits of existing medications for addictionand notes that theavailable drugs might work better. We would liketo haveseen more ink givento the role ofbehavioralapproaches in the management of addiction, which are supported by considerable evidence. However,the story does acknowledgethatvaccines "would likely be used alongside psychological therapy."We'll call it good enough for a satisfactory. The article helpfully states that "It could be years, if ever, before any vaccines to treat addiction reach the market." The article does a good job of describing how far along the various experimental vaccines mentioned in the article are in their development. Although the story could haveprovided more background on the history ofanti-addiction vaccines (aheroin vaccine was explored in the 1970s), the treatments being explored now are different fromanything currently available. So we don't think this story overstates thenoveltyof the research. This story is not based on a news release.

Ex Output:
Quest for Vaccines to Treat Addiction

Ex Input:
Ahead of an anticipated shortage of medical supplies, hospital staff met in a conference room south of Seattle to make homemade masks for the doctors, nurses and other healthcare professionals on the frontline of tackling the coronavirus outbreak. "We're days away from running out of the equipment we need," said Melissa Tizon, Associate Vice President of Providence St. Joseph Health, which runs 51 hospitals across five western states. "We're expecting more shipments later on but until then we've got to improvise." With coronavirus cases surging past 13,000 in the United State, health care workers are dealing with not only a shortage of masks but also surgical gowns and protective eye gear. President Donald Trump, speaking about medical gear at a White House briefing on Thursday, said "millions of masks" were in production, but did not give details. "We have helped out, and there are right now millions of masks being made. But this is really for the local governments, governors and people within the state, depending on the way they divided it up. And they'll do that, and they're doing a very good job of it." When asked by a reporter at the briefing why the increased production of masks was not reaching hospitals, Trump said the medical system was "obsolete" and the production system "wasn't meant for this" emergency. "Nobody knew there'd be a pandemic or an epidemic of this proportion," Trump said. "Nobody has ever seen anything like this before." Vice President Mike Pence said at the same briefing, "We've vastly increased the supply of medical masks, and we're going to continue to put a priority on making sure that we're calling on industry at every level." Meanwhile, many hospitals in other states have issued emergency calls for private companies to donate face masks and other items that can be used as medical protective gear. The Illinois Health and Hospital Association on Thursday, made that plea to help the state's 200 hospitals, asking for donations of masks from construction companies, dentists, veterinarians and any other group that might have the masks, called N95s. "Hospitals all over the state are in jeopardy of potentially running out of critically needed protective medical supplies," said the associations president and chief executive officer A.J. Wilhelmi.

Ex Output:
Faced with a shortage of face masks, some U.S. doctors make their own.